Welcome to our dedicated page for Selectquote SEC filings (Ticker: SLQT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
SelectQuote, Inc. (NYSE: SLQT) files a range of documents with the U.S. Securities and Exchange Commission that provide detailed information about its insurance distribution and healthcare services businesses. These SEC filings cover topics such as financial results, segment performance, corporate governance matters and material financing agreements.
For SelectQuote, current reports on Form 8-K are particularly relevant for tracking key events. Recent 8-K filings describe the company’s entry into a new credit agreement that established a senior secured term loan and a senior secured revolving credit facility, with proceeds used in part to repay a prior credit facility and support working capital. Other 8-Ks report quarterly and annual financial results for the Senior, Healthcare Services and Life segments, including metrics such as Medicare Advantage policy approvals, SelectRx membership and life premium volumes. Additional 8-K disclosures cover matters submitted to stockholders at the annual meeting, including director elections, auditor ratification and advisory votes on executive compensation.
On this page, users can access SelectQuote’s 10-K annual reports and 10-Q quarterly reports, which provide comprehensive discussions of the company’s business model, segment results, risk factors and accounting policies. Filings related to credit agreements and amendments detail the terms, covenants and collateral securing the company’s debt. Proxy statements and associated filings explain the company’s governance structure and compensation programs.
Stock Titan enhances these documents with AI-powered summaries that highlight the most important points from lengthy filings, including revenue drivers in the Senior and Healthcare Services segments, pharmacy-related risks and debt structure changes. Users can also review insider transaction reports on Form 4, along with real-time updates from EDGAR, to monitor equity transactions by SelectQuote officers and directors.
SelectQuote, Inc. entered into a new senior secured credit agreement on January 8, 2026, providing a $325 million senior secured term loan and a $90 million senior secured revolving credit facility. About $313.8 million of the term loan proceeds were used to fully repay all outstanding amounts under the company’s previous credit facility, with the balance and the revolver available for working capital and other general corporate purposes.
The term loan bears interest at either SOFR, with a 3.00% floor, plus 6.50% or a base rate plus 5.50%, and amortizes quarterly at 0.625% of the initial principal amount until June 30, 2027, and 1.25% thereafter. The revolving credit facility bears interest at either SOFR, with a 3.00% floor, plus 4.00% or a base rate plus 3.00%, and includes capacity for up to $5.0 million in letters of credit. The new facility is secured by substantially all assets of SelectQuote and certain subsidiaries, includes financial covenants on fixed charge coverage and liquidity, and replaces the prior Ares-led credit agreement, which was terminated on the closing date.
SelectQuote reported voting results from its 2025 Annual Meeting. Two Class III directors were elected: Denise L. Devine (65,350,226 votes for; 17,656,400 withheld) and Donald L. Hawks III (67,920,342 for; 15,086,284 withheld). Stockholders also ratified Deloitte & Touche LLP as independent auditor with 112,814,953 votes for, 1,156,892 against, and 472,083 abstentions.
The advisory vote on executive compensation passed with 79,848,312 votes for, 3,006,318 against, and 151,996 abstentions. A total of 114,443,928 shares were represented in person or by proxy, out of 175,884,846 shares outstanding as of the September 23, 2025 record date.
SelectQuote (SLQT) director reported equity changes on 11/11/2025. 52,631 restricted stock units vested in full and converted into common stock at $0. The director also received a new grant of 106,250 RSUs that will vest in full on the date of the Company’s 2026 Annual Meeting of Stockholders, subject to continued Board service. Following the transactions, the director holds 363,214 shares directly and 38,500 shares indirectly through Devanny LLC.
SelectQuote (SLQT) director Mr. Hawks reported equity transactions on 11/11/2025. 52,631 restricted stock units vested and were settled into common stock at a stated price of $0, and he now directly holds 513,214 shares.
He also received a new grant of 106,250 restricted stock units that vest in full on the date of the Company’s 2026 Annual Meeting of Stockholders, subject to continued Board service. Separately, the filing lists indirect holdings of 8,877,872 shares owned by BEP III LLC, 6,911,600 shares owned by BEP III Co-Invest LLC, and 1,889,285 shares owned by SQ Co-investors LLC, with a pecuniary-interest disclaimer.
SelectQuote, Inc. (SLQT) reported insider equity activity by a director on 11/11/2025. The filing shows 52,631 shares of common stock were acquired at $0 upon settlement of previously awarded RSUs (code M), bringing the director’s directly held shares to 371,214 after the transaction.
On the same date, the director received a new award of 106,250 restricted stock units under the 2020 Omnibus Incentive Plan. According to the terms, the award will vest in full on the date of the Company’s 2026 Annual Meeting of Stockholders, subject to continued Board service as of that date. Each RSU represents the right to receive one share of common stock.
SelectQuote, Inc. (SLQT) reported insider equity activity by a director. On 11/11/2025, 52,631 shares of common stock were acquired at $0 following the vesting and settlement of previously granted restricted stock units (transaction code M). After this event, beneficial ownership stood at 363,214 common shares, held directly.
The filing also reports a new award of 106,250 restricted stock units granted on 11/11/2025 (transaction code A). According to the award terms, these RSUs vest in full on the date of the Company’s 2026 Annual Meeting of Stockholders, subject to continued Board service.
SelectQuote (SLQT) Form 4: A director reported equity changes on 11/11/2025. An RSU award vested and settled into 52,631 shares (code M, at $0), bringing directly held common shares to 513,214.
The director also received a new grant of 106,250 RSUs that vest in full on the Company’s 2026 Annual Meeting of Stockholders, subject to continued board service. Indirect beneficial holdings are listed as 8,877,872 (BEP III LLC), 6,911,600 (BEP III Co‑Invest LLC), and 1,889,285 (SQ Co‑investors LLC), with a footnote limiting beneficial ownership to pecuniary interests.
SelectQuote, Inc. (SLQT) reported an insider equity award. A director received 106,250 restricted stock units (RSUs) on 11/11/2025 under the Company’s 2020 Omnibus Incentive Plan. Each RSU represents the right to receive one share of common stock, par value $0.01 per share.
The RSUs vest in full on the date of the Company’s 2026 Annual Meeting of Stockholders, subject to continued board service through that date. Following the grant, the reporting person beneficially owns 106,250 shares on a direct basis.
SelectQuote, Inc. reported results for the quarter ended September 30, 2025. Total revenue was $328.8 million, up from $292.3 million, driven by Pharmacy revenue of $218.5 million versus $152.9 million. Commissions and other services were $110.3 million versus $139.4 million.
Loss from operations widened to $(40.7) million from $(12.0) million as costs rose with volume. Net interest expense improved to $(11.8) million from $(23.0) million. A $15.0 million non‑cash gain from change in fair value of warrants reduced overall loss, resulting in net loss of $(30.5) million, compared with $(44.5) million a year ago. After $17.5 million of accumulated dividends and accretion on Senior Non‑Convertible Preferred Stock, net loss attributable to common shareholders was $(47.9) million (basic and diluted EPS $(0.26)).
Cash, cash equivalents and restricted cash ended at $15.7 million. Operating cash flow was $(21.6) million. Debt totaled $393.1 million, including Term Loans of $310.4 million and a $15.0 million revolving balance; the company was in compliance with covenants. Shares outstanding were 175,946,798 as of September 30, 2025.
SelectQuote, Inc. announced financial results for its first quarter ended September 30, 2025. The company furnished a press release and investor presentation as Exhibits 99.1 and 99.2, which are incorporated by reference.
The materials are furnished under Item 2.02 and are not deemed filed for purposes of Section 18 of the Exchange Act, nor incorporated into other filings unless specifically referenced. The filing also lists Exhibit 104 for the cover page Inline XBRL data.
FAQ
What is the current stock price of Selectquote (SLQT)?
What is the market cap of Selectquote (SLQT)?
